<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38725341</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1862-1783</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of Zhejiang University. Science. B</Title><ISOAbbreviation>J Zhejiang Univ Sci B</ISOAbbreviation></Journal><ArticleTitle>Exosomal <i>let-7a-5p</i> derived from human umbilical cord mesenchymal stem cells alleviates coxsackievirus B3-induced cardiomyocyte ferroptosis via the SMAD2/ZFP36 signal axis.</ArticleTitle><Pagination><StartPage>422</StartPage><EndPage>437</EndPage><MedlinePgn>422-437</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1631/jzus.B2300077</ELocationID><ELocationID EIdType="pii" ValidYN="Y">1673-1581(2024)05-0422-16</ELocationID><Abstract><AbstractText>Viral myocarditis (VMC) is one of the most common acquired heart diseases in children and teenagers. However, its pathogenesis is still unclear, and effective treatments are lacking. This study aimed to investigate the regulatory pathway by which exosomes alleviate ferroptosis in cardiomyocytes (CMCs) induced by coxsackievirus B3 (CVB3). CVB3 was utilized for inducing the VMC mouse model and cellular model. Cardiac echocardiography, left ventricular ejection fraction (LVEF), and left ventricular fractional shortening (LVFS) were implemented to assess the cardiac function. In CVB3-induced VMC mice, cardiac insufficiency was observed, as well as the altered levels of ferroptosis-related indicators (glutathione peroxidase 4 (GPX4), glutathione (GSH), and malondialdehyde (MDA)). However, exosomes derived from human umbilical cord mesenchymal stem cells (hucMSCs-exo) could restore the changes caused by CVB3 stimulation. <i>Let-7a-5p</i> was enriched in hucMSCs-exo, and the inhibitory effect of hucMSCs-exo<i><sup>let-7a-5p</sup></i> <sup>mimic</sup> on CVB3-induced ferroptosis was higher than that of hucMSCs-exo<sup>mimic NC</sup> (NC: negative control). Mothers against decapentaplegic homolog 2 (SMAD2) increased in the VMC group, while the expression of zinc-finger protein 36 (ZFP36) decreased. <i>Let-7a-5p</i> was confirmed to interact with <i>SMAD2</i> messenger RNA (mRNA), and the SMAD2 protein interacted directly with the ZFP36 protein. Silencing <i>SMAD2</i> and overexpressing <i>ZFP36</i> inhibited the expression of ferroptosis-related indicators. Meanwhile, the levels of GPX4, solute carrier family 7, member 11 (SLC7A11), and GSH were lower in the <i>SMAD2</i> overexpression plasmid (oe-<i>SMAD2</i>)+<i>let-7a-5p</i> mimic group than in the oe-NC+<i>let-7a-5p</i> mimic group, while those of MDA, reactive oxygen species (ROS), and Fe<sup>2+</sup> increased. In conclusion, these data showed that ferroptosis could be regulated by mediating <i>SMAD2</i> expression. Exo-<i>let-7a-5p</i> derived from hucMSCs could mediate <i>SMAD2</i> to promote the expression of ZFP36, which further inhibited the ferroptosis of CMCs to alleviate CVB3-induced VMC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital, Sichuan University and School of Life Sciences of Fudan University, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yanan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yueting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital, Sichuan University and School of Life Sciences of Fudan University, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zuocheng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, the Third Xiangya Hospital, Central South University, Changsha 410013, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China. cyggly@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China. cyggly@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China. cyggly@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital, Sichuan University and School of Life Sciences of Fudan University, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu 610041, China. cyggly@126.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China. cyggly@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hanmin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu 610041, China. cyggly@126.com, liuhm@scu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, China. cyggly@126.com, liuhm@scu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NHC Key Laboratory of Chronobiology (Sichuan University), Chengdu 610041, China. cyggly@126.com, liuhm@scu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Joint Laboratory for Lung Development and Related Diseases of West China Second University Hospital, Sichuan University and School of Life Sciences of Fudan University, West China Institute of Women and Children's Health, West China Second University Hospital, Sichuan University, Chengdu 610041, China. cyggly@126.com, liuhm@scu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu 610041, China. cyggly@126.com, liuhm@scu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>chi</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022M712252</GrantID><Agency>the China Postdoctoral Science Foundation</Agency><Country /></Grant><Grant><GrantID>2023NSFSC1634</GrantID><Agency>the Natural Science Foundation of Sichuan Province, China</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>人脐带间充质干细胞来源的外泌体<i>let-7a-5p</i>通过SMAD2/ZFP36信号轴减轻柯萨奇病毒B3诱导的心肌细胞铁死亡.</VernacularTitle></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Zhejiang Univ Sci B</MedlineTA><NlmUniqueID>101236535</NlmUniqueID><ISSNLinking>1673-1581</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C542687">mirnlet7 microRNA, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.11.1.12</RegistryNumber><NameOfSubstance UI="D000080662">Phospholipid Hydroperoxide Glutathione Peroxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051899">Smad2 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497783">Smad2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="Y">Exosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000079403" MajorTopicYN="Y">Ferroptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="N">Myocarditis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="Y">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080662" MajorTopicYN="N">Phospholipid Hydroperoxide Glutathione Peroxidase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051899" MajorTopicYN="N">Smad2 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014470" MajorTopicYN="N">Umbilical Cord</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="chi"><AbstractText>病毒性心肌炎（VMC）是儿童和青少年最常见的获得性心脏病之一。其发病机制尚不明确，且缺乏有效的治疗方法。本研究旨在探讨外泌体减轻柯萨奇病毒B3（CVB3）诱导的心肌细胞（CMCs）铁死亡的调控通路。我们用CVB3诱导小鼠VMC模型和细胞模型，使用心脏超声心动图、左室射血分数（LVEF）和左室短轴缩短率（LVFS）评价心功能。在CVB3诱导的VMC小鼠中，我们观察到小鼠心功能不全和铁死亡相关指标（谷胱甘肽过氧化酶4（GPX4）、谷胱甘肽（GSH）和丙二醛（MDA））的表达失调。然而，人脐带间充质干细胞来源的外泌体（hucMSCs-exo）可以恢复CVB3引起的改变。<i>Let-7a-5p</i>富集于hucMSCs-exo中，且hucMSCs-exo<i><sup>let-7a-5p</sup></i> <sup>mimic</sup>对CVB3诱导的铁死亡的抑制作用高于hucMSCs-exo<sup>mimic NC</sup>。在VMC组中，<i>SMAD2</i>表达升高，而<i>ZFP36</i>表达降低。<i>Let-7a-5p</i>靶向<i>SMAD2</i>信使RNA（mRNA），且SMAD2蛋白与ZFP36蛋白直接相互作用。沉默<i>SMAD2</i>和过表达<i>ZFP36</i>均可抑制铁死亡相关指标的表达。同时，与oe-NC+<i>let-7a-5p</i> mimic组比较，oe-<i>SMAD2</i>+<i>let-7a-5p</i> mimic组中的GPX4、溶质载体家族7成员11（SLC7A11）和GSH水平降低，而MDA、活性氧（ROS）和Fe<sup>2+</sup>水平升高。综上所述，这些数据表明铁死亡可以通过介导SMAD2的表达来调节。HucMSCs来源的exo-<i>let-7a-5p</i>可以通过介导SMAD2促进ZFP36的表达，进一步抑制CMCs的铁死亡，从而缓解CVB3诱导的VMC。.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="chi"><AbstractText>病毒性心肌炎（VMC）是儿童和青少年最常见的获得性心脏病之一。其发病机制尚不明确，且缺乏有效的治疗方法。本研究旨在探讨外泌体减轻柯萨奇病毒B3（CVB3）诱导的心肌细胞（CMCs）铁死亡的调控通路。我们用CVB3诱导小鼠VMC模型和细胞模型，使用心脏超声心动图、左室射血分数（LVEF）和左室短轴缩短率（LVFS）评价心功能。在CVB3诱导的VMC小鼠中，我们观察到小鼠心功能不全和铁死亡相关指标（谷胱甘肽过氧化酶4（GPX4）、谷胱甘肽（GSH）和丙二醛（MDA））的表达失调。然而，人脐带间充质干细胞来源的外泌体（hucMSCs-exo）可以恢复CVB3引起的改变。<i>Let-7a-5p</i>富集于hucMSCs-exo中，且hucMSCs-exo <i> <sup>let-7a-5p</sup> </i> <sup> mimic</sup>对CVB3诱导的铁死亡的抑制作用高于hucMSCs-exo<sup>mimic NC</sup>。在VMC组中，<i>SMAD2</i>表达升高，而<i>ZFP36</i>表达降低。<i>Let-7a-5p</i>靶向<i>SMAD2</i>信使RNA（mRNA），且SMAD2蛋白与ZFP36蛋白直接相互作用。沉默<i>SMAD2</i>和过表达<i>ZFP36</i>均可抑制铁死亡相关指标的表达。同时，与oe-NC+<i>let-7a-5p</i> mimic组比较，oe-<i>SMAD2</i>+<i>let-7a-5p</i> mimic组中的GPX4、溶质载体家族7成员11（SLC7A11）和GSH水平降低，而MDA、活性氧（ROS）和Fe<sup>2+</sup>水平升高。综上所述，这些数据表明铁死亡可以通过介导SMAD2的表达来调节。HucMSCs来源的exo-<i>let-7a-5p</i>可以通过介导SMAD2促进ZFP36的表达，进一步抑制CMCs的铁死亡，从而缓解CVB3诱导的VMC。</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus B3 (CVB3)</Keyword><Keyword MajorTopicYN="N">Exosome</Keyword><Keyword MajorTopicYN="N">Ferroptosis</Keyword><Keyword MajorTopicYN="N">Let-7a-5p</Keyword><Keyword MajorTopicYN="N">Mothers against decapentaplegic homolog 2 (SMAD2)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38725341</ArticleId><ArticleId IdType="pmc">PMC11087186</ArticleId><ArticleId IdType="doi">10.1631/jzus.B2300077</ArticleId><ArticleId IdType="pii">1673-1581(2024)05-0422-16</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bao MH, Feng X, Zhang YW, et al. , 2013. Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci, 14(11): 23086-23102. 10.3390/ijms141123086</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms141123086</ArticleId><ArticleId IdType="pmc">PMC3856107</ArticleId><ArticleId IdType="pubmed">24284400</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaschella C, Nai A, Silvestri L, 2020. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica, 105(2): 260-272. 10.3324/haematol.2019.232124</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2019.232124</ArticleId><ArticleId IdType="pmc">PMC7012465</ArticleId><ArticleId IdType="pubmed">31949017</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Sang YT, Song XJ, et al. , 2021. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics, 11(8): 3932-3947. 10.7150/thno.53412</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.53412</ArticleId><ArticleId IdType="pmc">PMC7914354</ArticleId><ArticleId IdType="pubmed">33664871</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CY, Choong OK, Liu LW, et al. , 2019. MicroRNA let-7-TGFBR3 signalling regulates cardiomyocyte apoptosis after infarction. EBioMedicine, 46: 236-247. 10.1016/j.ebiom.2019.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.08.001</ArticleId><ArticleId IdType="pmc">PMC6712055</ArticleId><ArticleId IdType="pubmed">31401194</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Xie YQ, Shen E, et al. , 2011. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur J Pharmacol, 658(2-3): 168-174. 10.1016/j.ejphar.2011.02.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.02.040</ArticleId><ArticleId IdType="pubmed">21371462</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Comish PB, Tang DL, et al. , 2021. Characteristics and biomarkers of ferroptosis. Front Cell Dev Biol, 9: 637162. 10.3389/fcell.2021.637162</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.637162</ArticleId><ArticleId IdType="pmc">PMC7859349</ArticleId><ArticleId IdType="pubmed">33553189</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong LY, Wang Y, Zheng TT, et al. , 2021. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice. Stem Cell Res Ther, 12: 4. 10.1186/s13287-020-02072-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-02072-0</ArticleId><ArticleId IdType="pmc">PMC7789736</ArticleId><ArticleId IdType="pubmed">33407872</ArticleId></ArticleIdList></Reference><Reference><Citation>el Andaloussi S, Mäger I, Breakefield XO, et al. , 2013. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov, 12(5): 347-357. 10.1038/nrd3978</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd3978</ArticleId><ArticleId IdType="pubmed">23584393</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbo S, Maione R, Tripodi M, et al. , 2022. Next RNA therapeutics: the mine of non-coding. Int J Mol Sci, 23(13): 7471. 10.3390/ijms23137471</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137471</ArticleId><ArticleId IdType="pmc">PMC9267739</ArticleId><ArticleId IdType="pubmed">35806476</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu XH, Li YC, Chen KX, et al. , 2020. Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR-mediated autophagy flux pathway. J Cell Mol Med, 24(13): ‍7515-7530. 10.1111/jcmm.15378</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15378</ArticleId><ArticleId IdType="pmc">PMC7339183</ArticleId><ArticleId IdType="pubmed">32424968</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Zhang Y, Ni CY, et al. , 2020. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism. Theranostics, 10(5): 2293-2308. 10.7150/thno.39238</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.39238</ArticleId><ArticleId IdType="pmc">PMC7019162</ArticleId><ArticleId IdType="pubmed">32089743</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber SA, 2016. Viral myocarditis and dilated cardiomyopathy: etiology and pathogenesis. Curr Pharm Des, 22(4): 408-426. 10.2174/1381612822666151222160500</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151222160500</ArticleId><ArticleId IdType="pubmed">26696257</ArticleId></ArticleIdList></Reference><Reference><Citation>Inamdar AA, Inamdar AC, 2016. Heart failure: diagnosis, management and utilization. J Clin Med, 5(7): 62. 10.3390/jcm5070062</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm5070062</ArticleId><ArticleId IdType="pmc">PMC4961993</ArticleId><ArticleId IdType="pubmed">27367736</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang XJ, Stockwell BR, Conrad M, 2021. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol, 22(4): 266-282. 10.1038/s41580-020-00324-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00324-8</ArticleId><ArticleId IdType="pmc">PMC8142022</ArticleId><ArticleId IdType="pubmed">33495651</ArticleId></ArticleIdList></Reference><Reference><Citation>Krützfeldt J, Rajewsky N, Braich R, et al. , 2005. Silencing of microRNAs in vivo with ‘antagomirs’. Nature, 438(7068): 685-689. 10.1038/nature04303</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04303</ArticleId><ArticleId IdType="pubmed">16258535</ArticleId></ArticleIdList></Reference><Reference><Citation>Li DP, Wang Y, Jin XR, et al. , 2020. NK cell-derived exosomes carry miR-207 and alleviate depression-like symptoms in mice. J Neuroinflammation, 17: 126. 10.1186/s12974-020-01787-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01787-4</ArticleId><ArticleId IdType="pmc">PMC7178582</ArticleId><ArticleId IdType="pubmed">32321532</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Xie YW, Li LW, et al. , 2021. MicroRNA-30a modulates type I interferon responses to facilitate coxsackievirus B3 replication via targeting tripartite motif protein 25. Front Immunol, 11: 603437. 10.3389/fimmu.2020.603437</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.603437</ArticleId><ArticleId IdType="pmc">PMC7840606</ArticleId><ArticleId IdType="pubmed">33519812</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JH, Tu JH, Gao H, et al. , 2021. MicroRNA-425-3p inhibits myocardial inflammation and cardiomyocyte apoptosis in mice with viral myocarditis through targeting TGF-β1. Immun Inflamm Dis, 9(1): 288-298. 10.1002/iid3.392</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.392</ArticleId><ArticleId IdType="pmc">PMC7860592</ArticleId><ArticleId IdType="pubmed">33332750</ArticleId></ArticleIdList></Reference><Reference><Citation>Li KL, Yan GH, Huang HJ, et al. , 2022. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages. J Nanobiotechnol, 20: 38. 10.1186/s12951-021-01236-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-021-01236-1</ArticleId><ArticleId IdType="pmc">PMC8771624</ArticleId><ArticleId IdType="pubmed">35057811</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li Y, Li SQ, et al. , 2022. The nano delivery systems and applications of mRNA. Eur J Med Chem, 227: 113910. 10.1016/j.ejmech.2021.113910</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2021.113910</ArticleId><ArticleId IdType="pmc">PMC8497955</ArticleId><ArticleId IdType="pubmed">34689071</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XX, Xiong L, Wen Y, et al. , 2021. Comprehensive analysis of the tumor microenvironment and ferroptosis-related genes predict prognosis with ovarian cancer. Front Genet, 12: 774400. 10.3389/fgene.2021.774400</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.774400</ArticleId><ArticleId IdType="pmc">PMC8634641</ArticleId><ArticleId IdType="pubmed">34868262</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Yan XJ, Zhang YJ, et al. , 2022. Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy. J Nanobiotechnol, 20: 206. 10.1186/s12951-022-01421-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-022-01421-w</ArticleId><ArticleId IdType="pmc">PMC9052603</ArticleId><ArticleId IdType="pubmed">35488343</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Ma JY, Hu G, et al. , 2021. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients. PLoS ONE, 16(7): e0254368. 10.1371/journal.pone.0254368</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254368</ArticleId><ArticleId IdType="pmc">PMC8274920</ArticleId><ArticleId IdType="pubmed">34252149</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhang Y, Zhou SR, et al. , 2022. Circular RNA: an emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccines. J Control Release, 348: 84-94. 10.1016/j.jconrel.2022.05.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2022.05.043</ArticleId><ArticleId IdType="pmc">PMC9644292</ArticleId><ArticleId IdType="pubmed">35649485</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu M, Martin-Jaular L, Lavieu G, et al. , 2019. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol, 21(1): 9-17. 10.1038/s41556-018-0250-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0250-9</ArticleId><ArticleId IdType="pubmed">30602770</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy DE, de Jong OG, Brouwer M, et al. , 2019. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking. Exp Mol Med, 51(3): 1-12. 10.1038/s12276-019-0223-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0223-5</ArticleId><ArticleId IdType="pmc">PMC6418170</ArticleId><ArticleId IdType="pubmed">30872574</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao C, Xu W, Zhu W, et al. , 2008. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int, 32(1): 8-15. 10.1016/j.cellbi.2007.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellbi.2007.08.002</ArticleId><ArticleId IdType="pubmed">17904875</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodríguez-Graciani KM, Chapa-Dubocq XR, Ayala-Arroyo EJ, et al. , 2022. Effects of ferroptosis on the metabolome in cardiac cells: the role of glutaminolysis. Antioxidants (Basel), 11(2): 278. 10.3390/antiox11020278</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11020278</ArticleId><ArticleId IdType="pmc">PMC8868370</ArticleId><ArticleId IdType="pubmed">35204160</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao MY, Xu Q, Wu ZR, et al. , 2020. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate IL-6-induced acute liver injury through miR-455-3p. Stem Cell Res Ther, 11: 37. 10.1186/s13287-020-1550-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-020-1550-0</ArticleId><ArticleId IdType="pmc">PMC6979401</ArticleId><ArticleId IdType="pubmed">31973730</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva AKA, Morille M, Piffoux M, et al. , 2021. Development of extracellular vesicle-based medicinal products: a position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs ‒ EVOLVE France”. Adv Drug Deliv Rev, 179: 114001. 10.1016/j.addr.2021.114001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2021.114001</ArticleId><ArticleId IdType="pubmed">34673131</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun LF, Zhu M, Feng W, et al. , 2019. Exosomal miRNA let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage. Oxid Med Cell Longev, 2019: 4506303. 10.1155/2019/4506303</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4506303</ArticleId><ArticleId IdType="pmc">PMC6948326</ArticleId><ArticleId IdType="pubmed">31949877</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun YT, Chen P, Zhai BT, et al. , 2020. The emerging role of ferroptosis in inflammation. Biomed Pharmacother, 127: 110108. 10.1016/j.biopha.2020.110108</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110108</ArticleId><ArticleId IdType="pubmed">32234642</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur D, Taliaferro O, Atkinson M, et al. , 2022. Inhibition of nuclear factor κB in the lungs protect bleomycin-induced lung fibrosis in mice. Mol Biol Rep, 49(5): 3481-3490. 10.1007/s11033-022-07185-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07185-8</ArticleId><ArticleId IdType="pmc">PMC9174314</ArticleId><ArticleId IdType="pubmed">35083615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueta M, Nishigaki H, Komai S, et al. , 2023. Positive regulation of innate immune response by miRNA-let-7a-5p. Front Genet, 13: 1025539. 10.3389/fgene.2022.1025539</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.1025539</ArticleId><ArticleId IdType="pmc">PMC9858567</ArticleId><ArticleId IdType="pubmed">36685889</ArticleId></ArticleIdList></Reference><Reference><Citation>Velot É, Madry H, Venkatesan JK, et al. , 2021. Is extracellular vesicle-based therapy the next answer for cartilage regeneration? Front Bioeng Biotechnol, 9: 645039. 10.3389/fbioe.2021.645039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2021.645039</ArticleId><ArticleId IdType="pmc">PMC8102683</ArticleId><ArticleId IdType="pubmed">33968913</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang GY, Yuan JT, Cai X, et al. , 2020. HucMSC-exosomes carrying miR-326 inhibit neddylation to relieve inflammatory bowel disease in mice. Clin Transl Med, 10(2): e113. 10.1002/ctm2.113</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.113</ArticleId><ArticleId IdType="pmc">PMC7403704</ArticleId><ArticleId IdType="pubmed">32564521</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TT, Liu Y, Cao Y, et al. , 2022. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic therapy of glioblastoma. Adv Mater, 34(15): 2110364. 10.1002/adma.202110364</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adma.202110364</ArticleId><ArticleId IdType="pubmed">35133042</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia YZ, Shan GF, Yang H, et al. , 2021. Cisatracurium regulates the CXCR4/let-7a-5p axis to inhibit colorectal cancer progression by suppressing TGF-β/SMAD2/3 signalling. Chem Biol Interact, 339: 109424. 10.1016/J.CBI.2021.109424</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CBI.2021.109424</ArticleId><ArticleId IdType="pubmed">33617803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C, Zhou QY, Wu J, et al. , 2021. Csi-let-7a-5p delivered by extracellular vesicles from a liver fluke activates M1-like macrophages and exacerbates biliary injuries. Proc Natl Acad Sci USA, 118(46): e2102206118. 10.1073/pnas.2102206118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2102206118</ArticleId><ArticleId IdType="pmc">PMC8609646</ArticleId><ArticleId IdType="pubmed">34772807</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan XQ, Li TF, Shi L, et al. , 2021. Human umbilical cord mesenchymal stem cells deliver exogenous miR-26a-5p via exosomes to inhibit nucleus pulposus cell pyroptosis through METTL14/NLRP3. Mol Med, 27: 91. 10.1186/s10020-021-00355-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00355-7</ArticleId><ArticleId IdType="pmc">PMC8375162</ArticleId><ArticleId IdType="pubmed">34412584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu DS, Liu S, Huang K, et al. , 2022. Intrapericardial exosome therapy dampens cardiac injury via activating Foxo3. Circ Res, 131(10): e135-e150. 10.1161/circresaha.122.321384</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.122.321384</ArticleId><ArticleId IdType="pmc">PMC9667926</ArticleId><ArticleId IdType="pubmed">36252111</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu JM, Liu B, Wang ZY, et al. , 2019. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p/PTEN-mediated VSMC migration and proliferation. Theranostics, 9(23): 6901-6919. 10.7150/thno.37357</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.37357</ArticleId><ArticleId IdType="pmc">PMC6815950</ArticleId><ArticleId IdType="pubmed">31660076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>